Early research (Phase 1)Study completedNCT00965731
What this trial is testing
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 27